Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$191.17 - $325.63 $75.5 Million - $129 Million
-395,062 Reduced 44.37%
495,358 $161 Million
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $84.1 Million - $113 Million
522,447 Added 141.98%
890,420 $170 Million
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $62.5 Million - $91.3 Million
321,500 Added 691.8%
367,973 $73.3 Million
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $25.7 Million - $34.9 Million
-115,306 Reduced 71.27%
46,473 $13.3 Million
Q1 2023

May 15, 2023

SELL
$175.41 - $217.92 $3.86 Million - $4.79 Million
-21,993 Reduced 11.97%
161,779 $35.1 Million
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $16.5 Million - $23.9 Million
80,540 Added 78.02%
183,772 $37.8 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $20.2 Million - $32.1 Million
103,232 New
103,232 $28.7 Million
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $4.77 Million - $7.73 Million
-37,289 Reduced 43.46%
48,505 $10.1 Million
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $8.21 Million - $12 Million
49,723 Added 137.85%
85,794 $15.3 Million
Q3 2021

Nov 15, 2021

SELL
$163.99 - $235.57 $8.3 Million - $11.9 Million
-50,608 Reduced 58.39%
36,071 $7.43 Million
Q2 2021

Aug 16, 2021

SELL
$131.45 - $201.49 $3.58 Million - $5.49 Million
-27,264 Reduced 23.93%
86,679 $16.4 Million
Q1 2021

May 17, 2021

BUY
$92.73 - $142.05 $3.32 Million - $5.09 Million
35,836 Added 45.88%
113,943 $14.8 Million
Q4 2020

Feb 16, 2021

SELL
$67.44 - $103.72 $5.22 Million - $8.03 Million
-77,451 Reduced 49.79%
78,107 $8.1 Million
Q3 2020

Nov 16, 2020

SELL
$42.79 - $75.8 $14.4 Million - $25.5 Million
-336,192 Reduced 68.37%
155,558 $11.8 Million
Q2 2020

Aug 14, 2020

SELL
$27.25 - $47.53 $5.03 Million - $8.77 Million
-184,582 Reduced 27.29%
491,750 $23.3 Million
Q1 2020

May 15, 2020

BUY
$23.16 - $47.74 $9.08 Million - $18.7 Million
392,183 Added 138.02%
676,332 $22.4 Million
Q4 2019

Feb 14, 2020

BUY
$29.4 - $44.98 $3.32 Million - $5.08 Million
112,878 Added 65.91%
284,149 $12.5 Million
Q3 2019

Nov 14, 2019

BUY
$29.71 - $55.23 $4.33 Million - $8.05 Million
145,771 Added 571.65%
171,271 $5.13 Million
Q2 2019

Aug 14, 2019

SELL
$29.73 - $66.02 $6.9 Million - $15.3 Million
-232,117 Reduced 90.1%
25,500 $1.46 Million
Q1 2019

May 15, 2019

BUY
$29.41 - $38.1 $7.58 Million - $9.82 Million
257,617 New
257,617 $0

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.